Skip to main content
Clinical Trials/NCT00758654
NCT00758654
Completed
Not Applicable

Strain-Encoded Cardiac Magnetic Resonance Imaging as an Adjunct for Dobutamine Stress Testing.

Heidelberg University1 site in 1 country320 target enrollmentJanuary 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
Heidelberg University
Enrollment
320
Locations
1
Primary Endpoint
Detection of coronary artery disease (>50% diameter stenosis) by invasive angiography
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purpose of this study is to compare the diagnostic value of SENC to that provided by conventional wall motion analysis for the detection of inducible ischemia during DS-MRI.High-dose dobutamine stress magnetic resonance imaging (DS-MRI) is safe and feasible for the diagnosis of coronary artery disease (CAD) in humans. However, the assessment of cine scans relies on the visual interpretation of regional wall motion, which is subjective. Recently, Strain-Encoded MRI (SENC) has been proposed for the direct color-coded visualization of myocardial strain.

Detailed Description

The assessment of inducible regional wall motion abnormalities during high-dose dobutamine stress magnetic resonance imaging (DS-MRI) is an established clinical method with high diagnostic and prognostic value for the evaluation of patients with coronary artery disease (CAD). However, the assessment of cine images relies on the visual interpretation of regional wall motion, which is subjective, and objective approaches for the detection of inducible ischemia with DS-MRI are still lacking. In our study Strain-Encoded-MRI (SENC) is used for the objective color-coded evaluation of regional myocardial strain during DS-MRI in patients with intermediate to high pretest probability for CAD. We anticipated that this technique would exhibit enhanced sensitivity for the detection of anatomically significant CAD compared to conventional wall motion reading, with invasive coronary angiography used as the standard reference.

Registry
clinicaltrials.gov
Start Date
January 2007
End Date
January 2011
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

G. Korosoglou

Prof. Dr.

Heidelberg University

Eligibility Criteria

Inclusion Criteria

  • Suspected or known coronary artery disease

Exclusion Criteria

  • General contraindication for a dobutamine stress or for an MRI examination
  • Age \< 18 yrs

Outcomes

Primary Outcomes

Detection of coronary artery disease (>50% diameter stenosis) by invasive angiography

Time Frame: 3 weeks

Secondary Outcomes

  • Long-term mortality and MACE(2 years)

Study Sites (1)

Loading locations...

Similar Trials